Danfeng Yu

1.1k total citations · 1 hit paper
19 papers, 638 citations indexed

About

Danfeng Yu is a scholar working on Epidemiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Danfeng Yu has authored 19 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Danfeng Yu's work include Pregnancy and preeclampsia studies (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Birth, Development, and Health (2 papers). Danfeng Yu is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Birth, Development, and Health (2 papers). Danfeng Yu collaborates with scholars based in China. Danfeng Yu's co-authors include Zejin Ou, Shihao Tang, Zhi Wang, Jing Pan, Danping Duan, Wenqiao He, Huan He, Yuanhao Liang, Qing Chen and Yongzhi Li and has published in prestigious journals such as Scientific Reports, Carbohydrate Polymers and BMC Public Health.

In The Last Decade

Danfeng Yu

18 papers receiving 633 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019

2021 425 citations Zejin Ou, Jing Pan et al. Frontiers in Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danfeng Yu China	9	259	105	103	89	67	19	638
Zejin Ou China	12	261 1.0×	123 1.2×	156 1.5×	89 1.0×	83 1.2×	30	781
Yu‐Duan Tsai Taiwan	18	106 0.4×	85 0.8×	107 1.0×	100 1.1×	44 0.7×	32	900
Rohan Sharma United States	13	248 1.0×	108 1.0×	72 0.7×	75 0.8×	95 1.4×	61	710
Stephen Trevick United States	7	100 0.4×	92 0.9×	66 0.6×	106 1.2×	32 0.5×	8	591
Fei Yang China	15	393 1.5×	105 1.0×	59 0.6×	90 1.0×	97 1.4×	67	689
Bindu Menon India	18	162 0.6×	217 2.1×	154 1.5×	129 1.4×	62 0.9×	65	1.1k
Masaru Iwasaki Japan	17	245 0.9×	225 2.1×	37 0.4×	52 0.6×	96 1.4×	57	853
Raghav Govindarajan United States	19	611 2.4×	183 1.7×	95 0.9×	75 0.8×	97 1.4×	126	1.1k
Stacey Kowal United States	7	357 1.4×	65 0.6×	32 0.3×	94 1.1×	83 1.2×	36	637
Suman Kushwaha India	19	166 0.6×	238 2.3×	117 1.1×	88 1.0×	259 3.9×	84	1.0k

Countries citing papers authored by Danfeng Yu

Since Specialization

Citations

This map shows the geographic impact of Danfeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danfeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danfeng Yu more than expected).

Fields of papers citing papers by Danfeng Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danfeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danfeng Yu. The network helps show where Danfeng Yu may publish in the future.

Co-authorship network of co-authors of Danfeng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Danfeng Yu. A scholar is included among the top collaborators of Danfeng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danfeng Yu. Danfeng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhang, Gan, Danfeng Yu, Huan Pan, et al.. (2025). Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS). Scientific Reports. 15(1). 42218–42218.

Yu, Danfeng, et al.. (2024). Combining experiments and bioinformatics to identify transforming growth factor-β1 as a key regulator in angiotensin II–induced trophoblast senescence. Placenta. 152. 31–38. 1 indexed citations

Lin, Ling, et al.. (2024). Investigating the molecular mechanism of traditional Chinese medicine for the treatment of placental syndromes by influencing inflammatory cytokines using the Mendelian randomization and molecular docking technology. Frontiers in Endocrinology. 14. 1290766–1290766. 8 indexed citations

Yu, Danfeng, et al.. (2023). Integrated bioinformatic analysis reveals NOS2 as a novel ferroptosis-related biomarker for pre-eclampsia. BMC Pregnancy and Childbirth. 23(1). 719–719. 1 indexed citations

Li, Yongzhi, Zejin Ou, Danfeng Yu, et al.. (2023). The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management. BMC Cancer. 23(1). 11 indexed citations

Yu, Danfeng, Zejin Ou, Huan He, et al.. (2022). Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019. BMC Gastroenterology. 22(1). 493–493. 4 indexed citations

Ou, Zejin, Yixian Ren, Shihao Tang, et al.. (2022). Global Trends in Death, Years of Life Lost, and Years Lived With Disability Caused by Breast Cancer Attributable to Secondhand Smoke From 1990 to 2019. Frontiers in Oncology. 12. 853038–853038. 6 indexed citations

Ou, Zejin, Danfeng Yu, Yuanhao Liang, et al.. (2022). Global burden of rheumatic heart disease: trends from 1990 to 2019. Arthritis Research & Therapy. 24(1). 138–138. 37 indexed citations

Ou, Zejin, Danfeng Yu, Yuanhao Liang, et al.. (2022). Global trends in incidence and death of neonatal disorders and its specific causes in 204 countries/territories during 1990–2019. BMC Public Health. 22(1). 360–360. 32 indexed citations

10.

He, Huan, Zejin Ou, Danfeng Yu, et al.. (2022). Spatial and Temporal Trends in HIV/AIDS Burden Among Worldwide Regions From 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019. Frontiers in Medicine. 9. 808318–808318. 12 indexed citations

11.

Li, Huibin, et al.. (2022). Prediction of Differentially Expressed Genes and a Diagnostic Signature of Preeclampsia via Integrated Bioinformatics Analysis. Disease Markers. 2022. 1–15. 7 indexed citations

12.

Ou, Zejin, Jing Pan, Shihao Tang, et al.. (2021). Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019. Frontiers in Public Health. 9. 776847–776847. 425 indexed citations breakdown →

13.

Ou, Zejin, Danfeng Yu, Yuanhao Liang, et al.. (2021). Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study. Infectious Diseases of Poverty. 10(1). 24–24. 31 indexed citations

14.

Ou, Zejin, Danfeng Yu, Yuanhao Liang, et al.. (2020). Analysis of the Global Burden of Disease study highlights the trends in death and disability‐adjusted life years of leukemia from 1990 to 2017. Cancer Communications. 40(11). 598–610. 33 indexed citations

15.

Yu, Danfeng, et al.. (2020). Correlation of changes in serum S100β, NSE and inflammatory factor levels with MMSE and MoCA in intracranial tumor patients with cognitive impairment. Oncology Letters. 20(2). 1968–1972. 13 indexed citations

16.

Wu, Jie, Xinchao Yu, Xuan Qian, et al.. (2017). Heparin-derived oligosaccharide inhibits vascular intimal hyperplasia in balloon-injured carotid artery. Chinese Journal of Natural Medicines. 15(6). 442–450. 5 indexed citations

17.

Wang, Hui‐Fang, et al.. (2017). Modulation of binding to vascular endothelial growth factor and receptor by heparin derived oligosaccharide. Carbohydrate Polymers. 174. 558–564. 7 indexed citations

18.

Yu, Danfeng, et al.. (2014). Effect of Heparin-Derived Oligosaccharide on bFGFR1 and bFGFR2 in Vascular Smooth Muscle Cells. Vascular and Endovascular Surgery. 48(4). 289–296. 4 indexed citations

19.

Zhang, Geng, et al.. (2005). [Clinical study of dynamic changes in acute phase proteins in sepsis].. PubMed. 17(4). 223–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact